Update on the safety of linezolid
- 21 June 2009
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Safety
- Vol. 8 (4) , 485-491
Abstract
(2009). Update on the safety of linezolid. Expert Opinion on Drug Safety: Vol. 8, No. 4, pp. 485-491.Keywords
This publication has 55 references indexed in Scilit:
- Epidemiological Profile of Linezolid‐Resistant Coagulase‐Negative StaphylococciClinical Infectious Diseases, 2006
- Linezolid in vitro: mechanism and antibacterial spectrumJournal of Antimicrobial Chemotherapy, 2003
- Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2003
- Linezolid: The First Oxazolidinone AntimicrobialAnnals of Internal Medicine, 2003
- Linezolid resistance in clinical isolates of Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2002
- Emerging Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Two Austrian Patients in the Same Intensive Care UnitEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Oxazolidinones Mechanism of Action: Inhibition of the First Peptide Bond FormationJournal of Biological Chemistry, 2001
- Linezolid resistance in a clinical isolate of Staphylococcus aureusThe Lancet, 2001
- Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolidThe Lancet, 2001
- The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in BacteriaAntimicrobial Agents and Chemotherapy, 1998